Literature DB >> 23076146

Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.

Cuiying Xiao1, Rui-Hong Wang, Tyler J Lahusen, Ogyi Park, Adeline Bertola, Takashi Maruyama, Della Reynolds, Qiang Chen, Xiaoling Xu, Howard A Young, Wan-Jun Chen, Bin Gao, Chu-Xia Deng.   

Abstract

The human body has a remarkable ability to regulate inflammation, a biophysical response triggered by virus infection and tissue damage. Sirt6 is critical for metabolism and lifespan; however, its role in inflammation is unknown. Here we show that Sirt6-null (Sirt6(-/-)) mice developed chronic liver inflammation starting at ∼2 months of age, and all animals were affected by 7-8 months of age. Deletion of Sirt6 in T cells or myeloid-derived cells was sufficient to induce liver inflammation and fibrosis, albeit to a lesser degree than that in the global Sirt6(-/-) mice, suggesting that Sirt6 deficiency in the immune cells is the cause. Consistently, macrophages derived from the bone marrow of Sirt6(-/-) mice showed increased MCP-1, IL-6, and TNFα expression levels and were hypersensitive to LPS stimulation. Mechanistically, SIRT6 interacts with c-JUN and deacetylates histone H3 lysine 9 (H3K9) at the promoter of proinflammatory genes whose expression involves the c-JUN signaling pathway. Sirt6-deficient macrophages displayed hyperacetylation of H3K9 and increased occupancy of c-JUN in the promoter of these genes, leading to their elevated expression. These data suggest that Sirt6 plays an anti-inflammatory role in mice by inhibiting c-JUN-dependent expression of proinflammatory genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076146      PMCID: PMC3516737          DOI: 10.1074/jbc.M112.415182

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

Authors:  Rui-Hong Wang; Hongtao Yu; Chu-Xia Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

Review 4.  Targeting inflammation by modulating the Jun/AP-1 pathway.

Authors:  Helia B Schonthaler; Juan Guinea-Viniegra; Erwin F Wagner
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

5.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Authors:  Eriko Michishita; Ronald A McCord; Elisabeth Berber; Mitomu Kioi; Hesed Padilla-Nash; Mara Damian; Peggie Cheung; Rika Kusumoto; Tiara L A Kawahara; J Carl Barrett; Howard Y Chang; Vilhelm A Bohr; Thomas Ried; Or Gozani; Katrin F Chua
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

6.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

Review 7.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

8.  SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.

Authors:  Marcia C Haigis; Chu-Xia Deng; Lydia W S Finley; Hyun-Seok Kim; David Gius
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

Review 9.  Mammalian sirtuins and energy metabolism.

Authors:  Xiaoling Li; Nevzat Kazgan
Journal:  Int J Biol Sci       Date:  2011-05-09       Impact factor: 6.580

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more
  69 in total

1.  The ubiquitin ligase CHIP prevents SirT6 degradation through noncanonical ubiquitination.

Authors:  Sarah M Ronnebaum; Yaxu Wu; Holly McDonough; Cam Patterson
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

2.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

Review 3.  SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Authors:  Andrew R Chang; Christina M Ferrer; Raul Mostoslavsky
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

Review 4.  The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2019-11-09       Impact factor: 4.473

5.  Cancer: Metabolism in 'the driver's seat.

Authors:  Luisa Tasselli; Katrin F Chua
Journal:  Nature       Date:  2012-12-20       Impact factor: 49.962

6.  SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts.

Authors:  Anna Engler; Fabienne Niederer; Kerstin Klein; Renate E Gay; Diego Kyburz; Giovanni G Camici; Steffen Gay; Caroline Ospelt
Journal:  J Mol Med (Berl)       Date:  2014-03-19       Impact factor: 4.599

Review 7.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

Review 8.  Sirtuins and Accelerated Aging in Scleroderma.

Authors:  Anne E Wyman; Sergei P Atamas
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

Review 9.  Chromatin and beyond: the multitasking roles for SIRT6.

Authors:  Sita Kugel; Raul Mostoslavsky
Journal:  Trends Biochem Sci       Date:  2014-01-14       Impact factor: 13.807

Review 10.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Mahesh P Gupta
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.